Skylands Capital LLC Has $1.26 Million Stock Position in Nature’s Sunshine Products, Inc. $NATR

Skylands Capital LLC trimmed its position in Nature’s Sunshine Products, Inc. (NASDAQ:NATR) by 70.9% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 52,650 shares of the company’s stock after selling 128,100 shares during the period. Skylands Capital LLC’s holdings in Nature’s Sunshine Products were worth $1,263,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. State of Alaska Department of Revenue acquired a new position in shares of Nature’s Sunshine Products during the 4th quarter worth about $31,000. Raymond James Financial Inc. bought a new position in shares of Nature’s Sunshine Products in the 2nd quarter valued at about $37,000. Clearstead Advisors LLC increased its stake in shares of Nature’s Sunshine Products by 16,025.0% during the 4th quarter. Clearstead Advisors LLC now owns 1,935 shares of the company’s stock worth $42,000 after purchasing an additional 1,923 shares during the last quarter. SG Americas Securities LLC acquired a new position in shares of Nature’s Sunshine Products during the 4th quarter worth about $121,000. Finally, Centiva Capital LP bought a new stake in shares of Nature’s Sunshine Products in the 3rd quarter valued at about $157,000. 79.40% of the stock is currently owned by institutional investors and hedge funds.

Nature’s Sunshine Products Stock Performance

Shares of NATR opened at $21.02 on Friday. The firm has a market cap of $369.53 million, a P/E ratio of 19.11 and a beta of 0.86. Nature’s Sunshine Products, Inc. has a 52 week low of $12.97 and a 52 week high of $28.14. The firm’s 50-day simple moving average is $22.68 and its 200 day simple moving average is $23.76.

Nature’s Sunshine Products (NASDAQ:NATR) last issued its quarterly earnings data on Thursday, May 7th. The company reported $0.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.20 by $0.10. Nature’s Sunshine Products had a net margin of 4.06% and a return on equity of 14.67%. The firm had revenue of $122.89 million during the quarter, compared to the consensus estimate of $122.15 million.

Insider Transactions at Nature’s Sunshine Products

In related news, EVP Nathan G. Brower sold 12,015 shares of the business’s stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $21.84, for a total value of $262,407.60. Following the completion of the sale, the executive vice president directly owned 43,438 shares in the company, valued at $948,685.92. The trade was a 21.67% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Daniel C. Norman sold 9,713 shares of the company’s stock in a transaction on Monday, June 1st. The shares were sold at an average price of $20.64, for a total value of $200,476.32. Following the completion of the transaction, the executive vice president directly owned 47,276 shares in the company, valued at approximately $975,776.64. This represents a 17.04% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 35,696 shares of company stock valued at $742,407. 3.10% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of research firms recently commented on NATR. Canaccord Genuity Group set a $37.00 price target on Nature’s Sunshine Products in a report on Friday, May 8th. Weiss Ratings lowered Nature’s Sunshine Products from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 9th. Finally, DA Davidson reaffirmed a “buy” rating and issued a $33.00 price objective on shares of Nature’s Sunshine Products in a research report on Monday, May 11th. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $35.00.

About Nature’s Sunshine Products

Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.

The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.